Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients

被引:69
|
作者
Toussaint, Nigel D. [1 ,2 ]
Polkinghorne, Kevan R. [1 ,2 ]
Kerr, Peter G. [1 ,2 ]
机构
[1] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Clayton, Vic, Australia
关键词
arterial compliance; B-type natriuretic peptide; cardiovascular disease; exercise; hemodialysis; pulse wave velocity;
D O I
10.1111/j.1542-4758.2008.00262.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular (CV) disease is the most common cause of mortality in end-stage kidney disease (ESKD), and arterial stiffness, measured by pulse wave velocity (PWV), is an independent predictor of all-cause and CV mortality. B-type natriuretic peptide (BNP) levels are high in patients with CV disease and ESKD, and increases in BNP may also be a marker of CV risk. Regular exercise has many benefits on quality of life and physical strength and may also improve CV risk, but few studies have addressed the impact of exercise on CV risk in ESKD. We performed a prospective cross-over trial in 19 hemodialysis (HD) patients to assess the impact of regular exercise on surrogate markers of CV risk-arterial compliance and BNP levels. Exercise involved the use of a bicycle ergometer for minimum 30 min at each HD session for 3 months, with a 1-month washout period. Group A (n=9) exercised for the first 3 months only, while group B (n= 10) performed no intradialytic exercise initially and exercised for 3 months at cross-over (month 4). Pulse wave velocity was performed using a SphygmoCor device, with concurrent measurements of BNP and other serum markers, at the commencement of the study, at 3 months, and on completion. The mean PWV (A: 10.4 +/- 3.1 m/s, B: 9.8 +/- 3.8 at baseline) showed a trend toward improvement with exercise (A: 8.7 +/- 2.7, p=0.07), and no significant change without (B: 10.5 +/- 3.6, p=0.3 1). After cross-over, there was an increase in PWV in group A with cessation of exercise (9.75 +/- 2.4, p=0.01 vs. 3 months) and an improvement in group B with exercise (9.33 +/- 2.3, p=0.11 vs. 3 months). When comparing PWV after 3 months of exercise vs. 3 months of no exercise (paired t test), there was a significant difference in favor of exercise (9.04 +/- 0.59 vs. 10.16 +/- 0.74, p=0.008). The mean BNP levels following 3 months of exercise were also lower than those after 3 months of no exercise (504.4 +/- 101.2 vs. 809.4 +/- 196.1 [N <100], p=0.047). There was an overall improvement in PWV, and to a lesser extent BNP levels, with 3 months of intradialytic exercise compared with no exercise, suggesting that regular exercise in ESKD may be associated with improvements in arterial compliance and a reduction in CV risk.
引用
收藏
页码:254 / 263
页数:10
相关论文
共 50 条
  • [21] B-type natriuretic peptide levels in asymptomatic patients with b-thalassaemia major
    Pavlakis, GP
    Bouki, K
    Komninos, K
    Vini, D
    Drosou, M
    Georgiou, D
    Papasteriadis, E
    Konstantellou, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 162A - 162A
  • [22] Mathematical model to predict B-type natriuretic peptide levels in haemodialysis patients
    Touzot, Maxime
    Seris, Pascal
    Maheas, Catherine
    Vanmassenhove, Jill
    Langlois, Anne-Lyse
    Moubakir, Kamal
    Laplanche, Sophie
    Petitclerc, Thierry
    Ridel, Christophe
    Lavielle, Marc
    NEPHROLOGY, 2020, 25 (01) : 82 - 89
  • [23] B-type natriuretic peptide levels in obese patients with advanced heart failure
    Horwich, TB
    Hamilton, MA
    Fonarow, GC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 85 - 90
  • [24] B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis
    Lauri, Gianfranco
    Rossi, Chiara
    Rubino, Mara
    Cosentino, Nicola
    Milazzo, Valentina
    Marana, Ivana
    Cabiati, Angelo
    Moltrasio, Marco
    De Metrio, Monica
    Grazi, Marco
    Campodonico, Jeness
    Assanelli, Emilio
    Riggio, Daniela
    Sandri, Maria Teresa
    Bonomi, Alice
    Veglia, Fabrizio
    Marenzi, Giancarlo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 318 - 323
  • [25] Clinical applications of B-type natriuretic peptide levels in the care of cardiovascular patients
    McCullough, PA
    CLINICA CHIMICA ACTA, 2005, 355 : S67 - S67
  • [26] B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation
    Jingtian Li
    Lexin Wang
    Heart and Vessels, 2006, 21 : 137 - 140
  • [27] The effect of diabetes on B-type natriuretic peptide levels in patients with acute dyspnea
    Maisel, AS
    Kazanegra, R
    McCord, J
    Nowak, RM
    Hollander, JE
    Duc, P
    Steg, GB
    Omland, T
    Wold-Knudsen, K
    Westheim, A
    Abraham, WT
    Storrow, AB
    Wu, AH
    McCullough, PA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 182A - 182A
  • [28] Elevated B-type Natriuretic Peptide Levels in Patients Undergoing Coronary Stenting
    Krishna, Abhay
    Kapoor, Aditya
    Kumar, Sudeep
    Tewari, Satyendra
    Garg, Naveen
    Goel, Pravin
    JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (06): : 240 - 245
  • [29] B-TYPE NATRIURETIC PEPTIDE LEVELS IN PATIENTS WITH PERICARDIAL EFFUSION UNDERGOING PERICARDIOCENTESIS
    Cosentino, Nicola
    Lauri, Gianfranco
    Rossi, Chiara
    Rubino, Mara
    Milazzo, Valentina
    Marana, Ivana
    Moltrasio, Marco
    De Metrio, Monica
    Grazi, Marco
    Campodonico, Jeness
    Marenzi, Giancarlo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1663 - 1663
  • [30] B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation
    Li, Jingtian
    Wang, Lexin
    HEART AND VESSELS, 2006, 21 (03) : 137 - 140